Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma

Circulating tumor cells (CTCs) have been shown as a surrogate for cancer progression and prognostication. We aimed to determine an association between CTCs and survival of hepatocellular carcinoma (HCC) patients. Peripheral blood was obtained from 73 HCC patients to enumerate for epithelial CTCs/8 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasoppokakorn, Thaninee, Buntho, Areeya, Ingrungruanglert, Praewphan, Tiyarattanachai, Thodsawit, Jaihan, Tassanan, Kulkraisri, Kittipat, Ariyaskul, Darlene, Phathong, Chonlada, Israsena, Nipan, Rerknimitr, Rungsun, Treeprasertsuk, Sombat, Chaiteerakij, Roongruedee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636215/
https://www.ncbi.nlm.nih.gov/pubmed/36333384
http://dx.doi.org/10.1038/s41598-022-21888-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636215/
https://www.ncbi.nlm.nih.gov/pubmed/36333384
http://dx.doi.org/10.1038/s41598-022-21888-9

Ejemplares similares